ghk-cu human clinical trial dosage Peptide Chart: Complete Reference Tables for Every Protocol GHK-CU Peptide Dosage Chart: Complete
Description
Contains 0.9% (9 mg/mL) benzyl alcohol added as a bacteriostatic preservative
NO ADVERSE EFFECTS
GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper) is as close to a panacea as peptides get
Do not use if this seal is broken or missing
Important Notice: GHK-Cu is intended for laboratory research purposes only
